US 9975862
Arylpiperazine derivatives and methods of utilizing same
granted A61KA61K31/538A61P
Quick answer
US patent 9975862 (Arylpiperazine derivatives and methods of utilizing same) held by REVIVA PHARMACEUTICALS, INC. expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/538, A61P, A61P25/00, A61P25/18